Xcite Uranium Inc. (CSE:XRI)
Canada · Delayed Price · Currency is CAD 0.2000
0.00 (0.00%)
At close: Aug 28, 2026
Xcite Uranium Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Cash & Equivalents | 4.1 | 5.48 | 0 | 0.11 | 0.01 | 0.15 |
Cash & Short-Term Investments | 4.1 | 5.48 | 0 | 0.11 | 0.01 | 0.15 |
Cash Growth | 5039.67% | 113999.35% | -95.51% | 1638.86% | -95.78% | - |
Other Receivables | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0 |
Receivables | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0 |
Prepaid Expenses | 0.9 | 0.2 | - | - | - | - |
Other Current Assets | - | - | - | - | 0.06 | 0.01 |
Total Current Assets | 5 | 5.69 | 0.03 | 0.13 | 0.07 | 0.16 |
Property, Plant & Equipment | 0.46 | 0.24 | 0.35 | 0.29 | 0.03 | 0.03 |
Total Assets | 5.47 | 5.93 | 0.39 | 0.41 | 0.1 | 0.19 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Accounts Payable | 0.04 | 0.44 | 0.14 | 0.03 | 0.01 | 0.01 |
Accrued Expenses | 0.26 | 0.04 | 0.24 | 0.15 | 0.06 | 0.02 |
Short-Term Debt | 0.02 | 0.02 | 0.03 | - | - | - |
Current Unearned Revenue | 0.07 | 0.12 | - | - | - | - |
Total Current Liabilities | 0.4 | 0.62 | 0.41 | 0.19 | 0.07 | 0.03 |
Total Liabilities | 0.4 | 0.62 | 0.41 | 0.19 | 0.07 | 0.03 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Common Stock | 7.63 | 7.06 | 0.9 | 0.74 | 0.25 | 0.25 |
Retained Earnings | -3.6 | -2.38 | -1.17 | -0.59 | -0.23 | -0.09 |
Comprehensive Income & Other | 1.04 | 0.63 | 0.24 | 0.08 | 0.01 | - |
Shareholders' Equity | 5.07 | 5.31 | -0.03 | 0.23 | 0.03 | 0.16 |
Total Liabilities & Equity | 5.47 | 5.93 | 0.39 | 0.41 | 0.1 | 0.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Total Debt | 0.02 | 0.02 | 0.03 | - | - | - |
Net Cash (Debt) | 4.07 | 5.46 | -0.03 | 0.11 | 0.01 | 0.15 |
Net Cash Growth | 7210.22% | - | - | 1638.86% | -95.78% | - |
Net Cash Per Share | 0.08 | 0.26 | -0.00 | 0.01 | 0.00 | 0.02 |
Filing Date Shares Outstanding | 79.48 | 74.62 | 16.77 | 15.58 | 8.51 | 8.51 |
Total Common Shares Outstanding | 79.48 | 74.62 | 16.77 | 15.58 | 8.51 | 8.51 |
Working Capital | 4.61 | 5.07 | -0.38 | -0.06 | 0 | 0.13 |
Book Value Per Share | 0.06 | 0.07 | -0.00 | 0.01 | 0.00 | 0.02 |
Tangible Book Value | 5.07 | 5.31 | -0.03 | 0.23 | 0.03 | 0.16 |
Tangible Book Value Per Share | 0.06 | 0.07 | -0.00 | 0.01 | 0.00 | 0.02 |